Skip to main content
. 2001 Jan;123(1):62–67. doi: 10.1046/j.1365-2249.2001.01370.x

Fig. 3.

Fig. 3

Effect of lipopolysaccharide (LPS; 1 mg/kg i.p., ▪) or sterile saline (control, □) on myeloperoxidase (MPO) activity in the lung (a), ileum (b) and kidney (c) at 6 h and 18 h post-injection. Data are the mean and s.e.m. mean of n = 5–12 samples. *P < 0·05 compared with controls.